The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

nephronpharm.com

Stage

Debt | Alive

Total Raised

$75M

Last Raised

$75M | 8 yrs ago

About Nephron Pharmaceuticals Corp

Nephron Pharmaceuticals Corporation is a privately owned manufacturer of generic inhalation solutions headquartered in Orlando, FL. Nephron specializes in blow-fill-seal (BFS) manufacturing, a technology that allows a vial of medication to be formed, filled and sealed in a continuous process without human intervention in a sterile, enclosed area.

Nephron Pharmaceuticals Corp Headquarter Location

4121 SW 34th Street

Orlando, Florida, 32811,

United States

800-443-3414

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Nephron Pharmaceuticals Corp Patents

Nephron Pharmaceuticals Corp has filed 7 patents.

The 3 most popular patent topics include:

  • Amines
  • Lung disorders
  • Muscarinic antagonists
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/11/2012

6/9/2015

Grant

Application Date

5/11/2012

Grant Date

6/9/2015

Title

Related Topics

Status

Grant

Latest Nephron Pharmaceuticals Corp News

10:12 ET Nephron Launches New Syringe Presentation

Jan 31, 2022

As Company Builds on Momentum, New Product Will Be Safer for Patients News provided by Share this article Share this article WEST COLUMBIA, S.C., Jan. 31, 2022 /PRNewswire/ -- Continuing to build on the momentum that comes with explosive growth, Nephron Pharmaceuticals Corporation today announced the launch of a brand new syringe presentation under the highly successful Nephron 503B Outsourcing Facility operation. The Cyclic Olefin Copolymer syringe (COC) has a glass-like appearance, but is break-resistant and lightweight. COC syringes are suitable for a variety of medications, including highly viscous drugs and provide for extended product shelf-life. The disconnected plunger allows for easier storage. The Cyclic Olefin Copolymer syringe (COC) has a glass-like appearance, but is break-resistant and lightweight. COC syringes are suitable for a variety of medications, including highly viscous drugs and provide for extended product shelf-life. The disconnected plunger allows for easier storage. As Company Builds on Momentum, New Product Will Be Safer for Patients. "From lifesaving drugs to cutting-edge automation, Nephron is known for the innovative new ways it approaches pharmaceutical manufacturing," said Nephron CEO Lou Kennedy. "That is why we could not be more excited or proud for the launch of our first COC syringe. In the same way we are transitioning products from traditional IV bags into Blow-Fill-Seal plastic IV bottles, this product launch represents a progressive, and necessary change, making life easier for health care professionals and products safer for patients." 8.4% Sodium Bicarbonate Injection is the first product Nephron is set to launch in a COC syringe. However, the company plans to move more products to this format in the coming months. A West Columbia, S.C.-based company, Nephron develops and produces safe, affordable generic inhalation solutions and suspension products. The company also operates an industry-leading 503B Outsourcing Facility division which produces pre-filled sterile syringes, luer-lock vials, IV bottles and IV bags for hospitals across America, in an effort to alleviate drug shortage needs. Nephron launched a CLIA-certified diagnostics lab last year where it tests people for COVID-19 and administers vaccinations. In July, Nephron announced the opening of Nephron Nitrile, a plant that will produce American-made, medical-grade nitrile gloves. Media Contact:

Nephron Pharmaceuticals Corp Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Nephron Pharmaceuticals Corp Rank

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.